Lonza | LONN - Current Assets


Lonza reported CHF8B in Current Assets for its fiscal semester ending in December of 2025.





Current Assets Change Date
Akzo Nobel EUR 7.53B 1.47B Mar/2026
Alcon AG USD 6.62B 171M Mar/2026
Almirall EUR 713.98M 69K Dec/2025
AstraZeneca USD 29.61B 890M Mar/2026
BASF EUR 31.68B 1.4B Dec/2025
Bayer EUR 35.3B 2.39B Mar/2026
Beiersdorf EUR 6.66B 8M Dec/2025
Covestro EUR 5.91B 259M Dec/2025
Demant DKK 10.08B 128M Dec/2025
Fresenius EUR 11.03B 1.03B Dec/2025
Fresenius Medical Care EUR 8.11B 209.55M Mar/2026
Geberit CHF 1.13B 151.3M Dec/2024
Genmab DKK 2.88B 1.59B Dec/2025
Givaudan CHF 4.07B 258M Dec/2025
GlaxoSmithKline GBP 17.76B 251M Mar/2026
GN Store Nord DKK 4.85B 3.79B Mar/2026
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Johnson Matthey GBP 3.94B 105M Jun/2026
Merck EUR 14.16B 932M Mar/2026
Novartis USD 26.61B 3.85B Mar/2026
Philips EUR 9.78B 148M Mar/2026
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.16B 789M Mar/2026
Sika AG CHF 4.41B 242.1M Dec/2025
Smith & Nephew USD 4.63B 169M Dec/2025
Solvay EUR 2.19B 34M Mar/2026
UCB EUR 6.05B 733M Dec/2025